| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
|
Lancet
|
2007
|
7.61
|
|
2
|
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
|
J Am Coll Cardiol
|
2005
|
4.05
|
|
3
|
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
|
J Am Coll Cardiol
|
2007
|
3.82
|
|
4
|
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
|
N Engl J Med
|
2005
|
3.60
|
|
5
|
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
|
Circulation
|
2007
|
3.40
|
|
6
|
Coronary collateral function long after drug-eluting stent implantation.
|
J Am Coll Cardiol
|
2006
|
3.07
|
|
7
|
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
|
JAMA
|
2012
|
2.49
|
|
8
|
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
|
Circulation
|
2009
|
2.47
|
|
9
|
Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
|
Circulation
|
2012
|
2.17
|
|
10
|
Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.
|
J Am Coll Cardiol
|
2010
|
2.16
|
|
11
|
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements.
|
Circulation
|
2007
|
1.90
|
|
12
|
Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study.
|
Am Heart J
|
2010
|
1.87
|
|
13
|
Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation.
|
JACC Cardiovasc Interv
|
2012
|
1.84
|
|
14
|
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.
|
EuroIntervention
|
2008
|
1.80
|
|
15
|
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization.
|
J Am Coll Cardiol
|
2013
|
1.76
|
|
16
|
High heart rate: a cardiovascular risk factor?
|
Eur Heart J
|
2006
|
1.73
|
|
17
|
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
|
EuroIntervention
|
2013
|
1.72
|
|
18
|
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.
|
Circulation
|
2011
|
1.72
|
|
19
|
Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation.
|
Am J Cardiol
|
2010
|
1.71
|
|
20
|
Amplatzer left atrial appendage occlusion: single center 10-year experience.
|
Catheter Cardiovasc Interv
|
2013
|
1.59
|
|
21
|
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
|
J Am Coll Cardiol
|
2007
|
1.54
|
|
22
|
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
|
Eur Heart J
|
2012
|
1.52
|
|
23
|
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation.
|
J Am Coll Cardiol
|
2012
|
1.44
|
|
24
|
Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement.
|
EuroIntervention
|
2014
|
1.44
|
|
25
|
Does the beta-blocker nebivolol increase coronary flow reserve?
|
Cardiovasc Drugs Ther
|
2007
|
1.43
|
|
26
|
Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement.
|
EuroIntervention
|
2014
|
1.42
|
|
27
|
Sirolimus versus paclitaxel coronary stents in clinical practice.
|
Catheter Cardiovasc Interv
|
2011
|
1.41
|
|
28
|
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement.
|
Nephrol Dial Transplant
|
2009
|
1.34
|
|
29
|
Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI).
|
Eur Heart J
|
2012
|
1.33
|
|
30
|
Aorto-right ventricular fistula after transfemoral aortic valve implantation.
|
J Invasive Cardiol
|
2010
|
1.25
|
|
31
|
Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up.
|
Am Heart J
|
2010
|
1.23
|
|
32
|
Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation.
|
JACC Cardiovasc Interv
|
2012
|
1.19
|
|
33
|
Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes.
|
EuroIntervention
|
2012
|
1.15
|
|
34
|
Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation.
|
EuroIntervention
|
2012
|
1.12
|
|
35
|
Invasive hemodynamic assessment of "paradoxical" low-flow severe aortic stenosis.
|
J Am Coll Cardiol
|
2013
|
1.05
|
|
36
|
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
|
Clin Res Cardiol
|
2015
|
1.05
|
|
37
|
A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.
|
JACC Cardiovasc Interv
|
2013
|
1.03
|
|
38
|
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents.
|
EuroIntervention
|
2014
|
1.02
|
|
39
|
Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
|
JACC Cardiovasc Interv
|
2013
|
1.01
|
|
40
|
Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis.
|
Circ Cardiovasc Interv
|
2012
|
1.01
|
|
41
|
Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience.
|
Eur Heart J
|
2009
|
0.99
|
|
42
|
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents.
|
Circ Cardiovasc Interv
|
2012
|
0.96
|
|
43
|
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
|
Int J Cardiol
|
2007
|
0.95
|
|
44
|
Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement.
|
J Cardiovasc Electrophysiol
|
2012
|
0.93
|
|
45
|
Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization.
|
J Am Coll Cardiol
|
2011
|
0.93
|
|
46
|
Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting.
|
Ann Thorac Surg
|
2011
|
0.93
|
|
47
|
Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation.
|
Eur Heart J
|
2013
|
0.92
|
|
48
|
Early exercise after coronary stenting is safe.
|
J Am Coll Cardiol
|
2003
|
0.91
|
|
49
|
A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study.
|
EuroIntervention
|
2009
|
0.91
|
|
50
|
Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.
|
Am J Cardiol
|
2011
|
0.90
|
|
51
|
Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation.
|
Eur J Cardiothorac Surg
|
2011
|
0.88
|
|
52
|
Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement.
|
Eur J Cardiothorac Surg
|
2012
|
0.88
|
|
53
|
Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
|
Circ Cardiovasc Interv
|
2013
|
0.87
|
|
54
|
2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.
|
JACC Cardiovasc Interv
|
2011
|
0.84
|
|
55
|
Acute coronary syndrome in patients younger than 30 years--aetiologies, baseline characteristics and long-term clinical outcome.
|
Swiss Med Wkly
|
2013
|
0.83
|
|
56
|
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study.
|
EuroIntervention
|
2011
|
0.83
|
|
57
|
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
|
Eur Heart J
|
2008
|
0.83
|
|
58
|
Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI.
|
PLoS One
|
2011
|
0.83
|
|
59
|
Transcatheter aortic valve implantation: the procedure.
|
Heart
|
2012
|
0.82
|
|
60
|
Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
|
Am Heart J
|
2010
|
0.82
|
|
61
|
Severe aortic stenosis and coronary artery disease.
|
EuroIntervention
|
2013
|
0.82
|
|
62
|
Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis.
|
J Thromb Thrombolysis
|
2013
|
0.82
|
|
63
|
Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure.
|
Clin Res Cardiol
|
2014
|
0.81
|
|
64
|
Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial.
|
Circulation
|
2005
|
0.80
|
|
65
|
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes.
|
JACC Cardiovasc Interv
|
2012
|
0.80
|
|
66
|
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
|
JACC Cardiovasc Interv
|
2012
|
0.79
|
|
67
|
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
|
EuroIntervention
|
2016
|
0.78
|
|
68
|
Very late restenosis of a sirolimus-eluting stent after left main coronary artery stenting.
|
Can J Cardiol
|
2007
|
0.78
|
|
69
|
Transapical access closure: the TA PLUG device.
|
Interact Cardiovasc Thorac Surg
|
2013
|
0.78
|
|
70
|
Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation.
|
EuroIntervention
|
2015
|
0.78
|
|
71
|
Transcatheter aortic valve implantation: the transfemoral access route is the default access.
|
EuroIntervention
|
2013
|
0.78
|
|
72
|
Deleterious effect of coronary brachytherapy on vasomotor response to exercise.
|
Circulation
|
2004
|
0.77
|
|
73
|
Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat.
|
EuroIntervention
|
2014
|
0.77
|
|
74
|
Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making.
|
EuroIntervention
|
2014
|
0.77
|
|
75
|
Transcatheter aortic valve implantation and cerebrovascular accidents.
|
EuroIntervention
|
2012
|
0.77
|
|
76
|
Transcatheter aortic valve implantation: prevention and management of complications.
|
Heart
|
2012
|
0.77
|
|
77
|
Anatomical suitability for transcatheter aortic valve implantation with complementary roles for 2 rivals.
|
JACC Cardiovasc Interv
|
2010
|
0.77
|
|
78
|
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis.
|
EuroIntervention
|
2017
|
0.76
|
|
79
|
Amplatzer left atrial appendage occlusion through a patent foramen ovale.
|
Catheter Cardiovasc Interv
|
2014
|
0.76
|
|
80
|
Stent thrombosis is associated with an impaired response to antiplatelet therapy.
|
J Am Coll Cardiol
|
2005
|
0.76
|
|
81
|
Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis.
|
EuroIntervention
|
2012
|
0.76
|
|
82
|
Off-label use and the spectre of drug-eluting stent thrombosis.
|
Circ Cardiovasc Interv
|
2009
|
0.76
|
|
83
|
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy.
|
Int J Cardiovasc Imaging
|
2015
|
0.75
|
|
84
|
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial.
|
JACC Cardiovasc Interv
|
2011
|
0.75
|
|
85
|
Thienopyridines, a safety net with holes in it.
|
Catheter Cardiovasc Interv
|
2003
|
0.75
|
|
86
|
Aortic stenosis and the right heart at risk: is transcatheter aortic valve implantation the better option?
|
Heart
|
2012
|
0.75
|
|
87
|
Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?
|
EuroIntervention
|
2014
|
0.75
|
|
88
|
Left ventricular guidewire pacing for transcatheter aortic valve implantation.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
89
|
Second valve implantation for the treatment of a malpositioned transcatheter aortic valve.
|
J Invasive Cardiol
|
2012
|
0.75
|
|
90
|
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
|
EuroIntervention
|
2010
|
0.75
|
|
91
|
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes.
|
EuroIntervention
|
2016
|
0.75
|
|
92
|
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation.
|
EuroIntervention
|
2015
|
0.75
|
|
93
|
Emergency transcatheter aortic valve implantation for decompensated aortic stenosis.
|
J Invasive Cardiol
|
2013
|
0.75
|
|
94
|
Ventricular prosthesis embolization during transapical aortic valve implantation: the role of transesophageal echocardiography in diagnosis and management.
|
J Am Soc Echocardiogr
|
2010
|
0.75
|
|
95
|
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
|
EuroIntervention
|
2013
|
0.75
|
|
96
|
Ad hoc percutaneous left atrial appendage closure.
|
J Invasive Cardiol
|
2013
|
0.75
|
|
97
|
Transapical implantation of a novel self-expanding sutureless aortic valve prosthesis.
|
J Heart Valve Dis
|
2010
|
0.75
|